Journal article
A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
- Abstract:
-
OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred and one individuals with CD4 cell counts < 100 cells/microL or < 200 cells/microL with nadir < 50 cells/microL were allocated to receive either 120 mg ADV (subsequently 60 mg) (n = 161) or...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- HIV medicine
- Volume:
- 3
- Issue:
- 4
- Pages:
- 229-238
- Publication date:
- 2002-10-01
- DOI:
- EISSN:
-
1468-1293
- ISSN:
-
1464-2662
- Source identifiers:
-
444420
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:444420
- UUID:
-
uuid:015de556-fc4c-4a55-a36c-08038dfa8d65
- Local pid:
- pubs:444420
- Deposit date:
- 2014-02-08
Terms of use
- Copyright date:
- 2002
If you are the owner of this record, you can report an update to it here: Report update to this record